Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1989 Jan;27(1):168–173. doi: 10.1128/jcm.27.1.168-173.1989

Detection of human papillomaviruses in exfoliated cervicovaginal cells by in situ DNA hybridization analysis.

C C Pao 1, C H Lai 1, S Y Wu 1, K C Young 1, P L Chang 1, Y K Soong 1
PMCID: PMC267254  PMID: 2536386

Abstract

A total of 851 specimens of exfoliated cervicovaginal cells and 27 specimens of male urethral smears obtained from 706 individuals with various clinical findings were examined for the presence of human papillomavirus (HPV) types 6, 11, 16, 18, 31, and 33 by in situ DNA hybridization analysis. The nonradioactive DNA in situ hybridization method used in this study showed no detectable cross-hybridization either among different types of HPV (except between types 6 and 11) or between HPV DNA and human cellular DNA. Furthermore, this system was found to be more sensitive than the Southern blotting method in detecting HPV. HPV was found in 233 of 276 (84.4%) and in 34 of 47 (72.3%) samples of cervicovaginal cells from patients with urogenital condylomata and cervical dysplasia, respectively. HPV was also detected in 6 of 39 (15.4%) women with normal cytological findings who were also symptom-free. Young women who were at low risk but were infected with HPV showed significantly reduced ratios of helper-inducer T lymphocytes to suppressor-cytotoxic T lymphocytes compared with those of uninfected normal controls (1.28 +/- 0.31 versus 2.47 +/- 0.64; P less than 0.001). This in situ DNA hybridization method can have broad application to the screening of HPV in early lesions and in normal-looking tissues and may be used to identify patients at risk of more serious or possibly malignant progression.

Full text

PDF
168

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burk R. D., Kadish A. S., Calderin S., Romney S. L. Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: correlation with biopsy results and Papanicolaou smear. Am J Obstet Gynecol. 1986 May;154(5):982–989. doi: 10.1016/0002-9378(86)90733-7. [DOI] [PubMed] [Google Scholar]
  2. Carson L. F., Twiggs L. B., Fukushima M., Ostrow R. S., Faras A. J., Okagaki T. Human genital papilloma infections: an evaluation of immunologic competence in the genital neoplasia-papilloma syndrome. Am J Obstet Gynecol. 1986 Oct;155(4):784–789. doi: 10.1016/s0002-9378(86)80021-7. [DOI] [PubMed] [Google Scholar]
  3. Cornelissen M. T., van der Velden K. J., Walboomers J. M., Briët M. A., Smits H. L., van der Noordaa J., ter Schegget J. Evaluation of different DNA-DNA hybridisation techniques in detection of HPV 16 DNA in cervical smears and biopsies. J Med Virol. 1988 May;25(1):105–114. doi: 10.1002/jmv.1890250114. [DOI] [PubMed] [Google Scholar]
  4. Dürst M., Gissmann L., Ikenberg H., zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3812–3815. doi: 10.1073/pnas.80.12.3812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gergely L., Czeglédy J., Hernády Z. Human papillomavirus frequency in normal cervical tissue. Lancet. 1987 Aug 29;2(8557):513–513. doi: 10.1016/s0140-6736(87)91824-1. [DOI] [PubMed] [Google Scholar]
  6. Guijon F. B., Paraskevas M., Brunham R. The association of sexually transmitted diseases with cervical intraepithelial neoplasia: a case-control study. Am J Obstet Gynecol. 1985 Jan 15;151(2):185–190. doi: 10.1016/0002-9378(85)90009-2. [DOI] [PubMed] [Google Scholar]
  7. Kung P., Goldstein G., Reinherz E. L., Schlossman S. F. Monoclonal antibodies defining distinctive human T cell surface antigens. Science. 1979 Oct 19;206(4416):347–349. doi: 10.1126/science.314668. [DOI] [PubMed] [Google Scholar]
  8. Lörincz A. T., Temple G. F., Patterson J. A., Jenson A. B., Kurman R. J., Lancaster W. D. Correlation of cellular atypia and human papillomavirus deoxyribonucleic acid sequences in exfoliated cells of the uterine cervix. Obstet Gynecol. 1986 Oct;68(4):508–512. [PubMed] [Google Scholar]
  9. McCance D. J., Campion M. J., Singer A. Non-invasive detection of cervical papillomavirus DNA. Lancet. 1986 Mar 8;1(8480):558–559. doi: 10.1016/s0140-6736(86)90912-8. [DOI] [PubMed] [Google Scholar]
  10. Millan D. W., Davis J. A., Torbet T. E., Campo M. S. DNA sequences of human papillomavirus types 11, 16, and 18 in lesions of the uterine cervix in the west of Scotland. Br Med J (Clin Res Ed) 1986 Jul 12;293(6539):93–96. doi: 10.1136/bmj.293.6539.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mitchell H., Drake M., Medley G. Prospective evaluation of risk of cervical cancer after cytological evidence of human papilloma virus infection. Lancet. 1986 Mar 15;1(8481):573–575. doi: 10.1016/s0140-6736(86)92807-2. [DOI] [PubMed] [Google Scholar]
  12. Porreco R., Penn I., Droegemueller W., Greer B., Makowski E. Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet Gynecol. 1975 Apr;45(4):359–364. [PubMed] [Google Scholar]
  13. Reid R., Stanhope C. R., Herschman B. R., Booth E., Phibbs G. D., Smith J. P. Genital warts and cervical cancer. I. Evidence of an association between subclinical papillomavirus infection and cervical malignancy. Cancer. 1982 Jul 15;50(2):377–387. doi: 10.1002/1097-0142(19820715)50:2<377::aid-cncr2820500236>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  14. Sato S., Okagaki T., Clark B. A., Twiggs L. B., Fukushima M., Ostrow R. S., Faras A. J. Sensitivity of koilocytosis, immunocytochemistry, and electron microscopy as compared to DNA hybridization in detecting human papillomavirus in cervical and vaginal condyloma and intraepithelial neoplasia. Int J Gynecol Pathol. 1986;5(4):297–307. doi: 10.1097/00004347-198612000-00002. [DOI] [PubMed] [Google Scholar]
  15. Schneider A., Kraus H., Schuhmann R., Gissmann L. Papillomavirus infection of the lower genital tract: detection of viral DNA in gynecological swabs. Int J Cancer. 1985 Apr 15;35(4):443–448. doi: 10.1002/ijc.2910350405. [DOI] [PubMed] [Google Scholar]
  16. Toon P. G., Arrand J. R., Wilson L. P., Sharp D. S. Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia. Br Med J (Clin Res Ed) 1986 Nov 15;293(6557):1261–1264. doi: 10.1136/bmj.293.6557.1261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wagner D., Ikenberg H., Boehm N., Gissmann L. Identification of human papillomavirus in cervical swabs by deoxyribonucleic acid in situ hybridization. Obstet Gynecol. 1984 Dec;64(6):767–772. [PubMed] [Google Scholar]
  18. Wickenden C., Steele A., Malcolm A. D., Coleman D. V. Screening for wart virus infection in normal and abnormal cervices by DNA hybridisation of cervical scrapes. Lancet. 1985 Jan 12;1(8420):65–67. doi: 10.1016/s0140-6736(85)91963-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES